CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the fourth quarter and year ending December 31, 2015 on Thursday, February 11, 2016, after the U.S. financial markets close.
Management will provide an update on the company, discuss fourth quarter and year-end 2015 results, and discuss expectations for the future via conference call on Thursday, February 11, 2016 at 4:30 p.m. ET. To access the call, please dial 877-312-7507 (domestic) or 631-813-4828 (international) five minutes prior to the start time and refer to conference ID 45176516. A replay of the call will be available beginning at 7:30 p.m. ET on February 11, 2016.
Management will provide an update on the company, discuss fourth quarter and year-end 2015 results, and discuss expectations for the future via conference call on Thursday, February 11, 2016 at 4:30 p.m. ET. To access the call, please dial 877-312-7507 (domestic) or 631-813-4828 (international) five minutes prior to the start time and refer to conference ID 45176516. A replay of the call will be available beginning at 7:30 p.m. ET on February 11, 2016.
